Abvc biopharma reports third quarter 2022 financial and operational results

Fremont, ca, nov. 14, 2022 (globe newswire) -- via newmediawire – abvc biopharma, inc. (nasdaq: abvc), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, cns, and ophthalmology, today announced its financial and operating results for the third quarter of 2022.  these results, including the financial statements included herein, can be found in the company's quarterly report on form 10-q that was filed earlier today with the securities and exchange commission.
ABVC Ratings Summary
ABVC Quant Ranking